Evidence map›Paper›PMID 29085409›Full record

ArticleAfrican health sciences2017

Repurposing metformin as a quorum sensing inhibitor in

Hisham A Abbas, Ahmed M Elsherbini, Moutaz A Shaldam

Open access · diamondAbstract read
In one paragraph

Article in African health sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Quorum Sensing and its Inhibition inCurrent drug targets · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Heliyon · 2024
    Article
  16. Profiling ofFrontiers in nutrition · 2024
    Article
  17. Cubeb (Frontiers in nutrition · 2024
    Article
  18. Article
  19. Dermato-cosmeceutical properties ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Hisham A AbbasDepartment of Microbiology and Immunology-Faculty of Pharmacy-Zagazig University- Zagazig- Egypt.
Ahmed M ElsherbiniHealth Sciences College-Umm Al Qura University, AlQunfudah, Saudi Arabia.
Moutaz A ShaldamDepartment of Medicinal Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
Delta University for Science and Technology · EGUmm al-Qura University · SAZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundQuorum sensing is a mechanism of intercellular communication that controls the production of virulence factors in

objectivesFinding a new quorum sensing inhibitor and determining its inhibitory activities against virulence factors of

methodsQuorum sensing was evaluated by estimation of violacein production by

resultsMetformin significantly reduced the production of violacein pigment. Significant inhibition of pyocyanin, hemolysin, protease and elastase was achieved. Metformin markedly decreased biofilm formation, swimming and twitching motilities and increased the sensitivity to oxidative stress. In the molecular docking study, metformin could bind to LasR by hydrogen bonding and electrostatic interaction and to rhlR by hydrogen bonding only.

conclusionMetformin can act as a quorum sensing inhibitor and virulence inhibiting agent that may be useful in the treatment of

Indexed as

Molecular Docking SimulationAnti-Bacterial AgentsBacterial ProteinsChromobacteriumHumansIndolesLocomotionMetforminMicrobial Sensitivity TestsOxidative StressProtein BindingPseudomonas aeruginosaQuorum SensingTrans-ActivatorsVirulenceVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsIndolesLasR protein, Pseudomonas aeruginosaMetforminRhlR protein, Pseudomonas aeruginosaTrans-ActivatorsviolaceinVirulence FactorsMetforminPseudomonas aeruginosaquorum sensingvirulence inhibition

Identifiers

PMID29085409
PMCPMC5656202
OpenAlexW2755004181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.